Home> Products> gliclaglaze met enhanced glycemic control

{ "products": [ { "_id": "66619373ccd5ce1a10759768", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "sitagliptin and metformin hydrochloride tablets", "description": "ST-GLIPTIN 100 \nSitagliptin (100mg)\nIntroduction to ST-GLIPTIN 100\nST-GLIPTIN 100 contains Sitagliptin 100mg, a medication primarily used for the management of type 2 diabetes mellitus. Sitagliptin belongs to a class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors, which help control blood sugar levels by enhancing the body’s own ability to regulate insulin after meals. This medication is typically used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nWhat is Sitagliptin?\nOverview of Sitagliptin\nSitagliptin is an oral diabetes medication that helps increase insulin production and decrease glucose production in the liver. It works by inhibiting the DPP-4 enzyme, which results in prolonged activity of incretin hormones. These hormones play a significant role in regulating glucose metabolism.\n\nMechanism of Action\nIncretin Hormones: Sitagliptin enhances the levels of incretin hormones, which increase insulin synthesis and release from pancreatic beta cells in response to meals.\nGlucose Regulation: It reduces the liver’s production of glucose, especially after meals, thereby helping to lower blood sugar levels.\nReduced Blood Sugar Spikes: By increasing insulin release and decreasing glucagon levels, Sitagliptin helps control blood sugar spikes after meals.\nBenefits of ST-GLIPTIN 100\nEffective Blood Sugar Management\nPostprandial Glucose Control: ST-GLIPTIN 100 helps manage postprandial (after-meal) blood sugar levels by enhancing the body’s natural response to meals.\nFasting Blood Sugar Control: It also helps in lowering fasting blood sugar levels, providing a balanced glycemic control throughout the day.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: ST-GLIPTIN 100 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nCombination Therapy: It can be used alone or in combination with other antidiabetic medications such as metformin, sulfonylureas, or insulin for enhanced glycemic control.\nAdditional Health Benefits\nWeight Neutral: Sitagliptin is generally weight neutral, making it a favorable option for patients concerned about weight gain associated with other diabetes medications.\nLow Risk of Hypoglycemia: When used alone, sitagliptin has a low risk of causing hypoglycemia compared to some other diabetes medications.\nHow to Use ST-GLIPTIN 100\nDosage and Administration\nRecommended Dosage: The typical dosage of ST-GLIPTIN 100 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take ST-GLIPTIN 100 regularly at the same time each day as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now", "price": 450.0, "discountamount": 135.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "diet", "food", "body", "meals", "water", "liver", "drugs", "EMAIL", "Order", "class", "adults", "option", "Action", "ability", "Support", "Low Risk", "readings", "Overview", "patients", "same time", "Mechanism", "metformin", "full glass", "one tablet", "ST-GLIPTIN", "Guidelines", "Optimal Use", "weight gain", "Adjustments", "information", "sterisonline", "DPP-4 enzyme", "Introduction", "best results", "Hypoglycemia", "sterispharma", "sulfonylureas", "CALL/WHATSAPP", "typical dosage", "Administration", "Consistent Use", "treatment plan", "Weight Neutral", "insulin release", "glucagon levels", "Exercise Adjunct", "natural response", "significant role", "Sitagliptin 100mg", "insulin synthesis", "incretin hormones", "excellent adjunct", "Recommended Dosage", "glucose production", "insulin production", "prolonged activity", "Glucose Regulation", "glucose metabolism", "Blood Sugar Control", "Diabetes Management", "healthcare provider", "individual response", "Combination Therapy", "pancreatic beta cells", "lifestyle modifications", "meal) blood sugar levels", "oral diabetes medication", "type 2 diabetes mellitus", "balanced glycemic control", "enhanced glycemic control", "other diabetes medications", "Additional Health Benefits", "Reduced Blood Sugar Spikes", "Postprandial Glucose Control", "other antidiabetic medications", "Effective Blood Sugar Management", "dipeptidyl peptidase-4 (DPP-4) inhibitors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1454, "imageuri": "https://productimages.withfloats.com/actual/66619377e874b19df8bb10f6.png", "tileimageuri": "https://productimages.withfloats.com/tile/66619377e874b19df8bb10f6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T10:46:11.53Z", "updatedon": "2026-01-24T07:31:15.432Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sitagliptin-and-metformin-hydrochloride-tablets/1454", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST-GLIPTIN 100 ", "category": "DIABETIC RANGE", "tags": [ "ST-GLIPTIN 100", "Sitagliptin (100mg)", "Sitagliptin 100mg side effects", "Sitagliptin 100 mg price", "Sitagliptin 100 mg brands in India", "", "Sitagliptin 100 mg dose", "Sitagliptin 50" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6a1ec0fb574466f5ec21abe8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Benfotiamine,Mecobalamin,Pyridoxine Hydrochloride,Folic Acid,Inositol & Alpha Lipoic Acid Capsules", "description": "Generate unique content Seo geo friendly At least 1500 words humanizes and long and detailed articles on composition “ gliclazide and dapagliflozin combination\n\n” using brand name “ GLICLAGLAZE DAPA 60-10” use composition in heading “gliclazide and dapagliflozin combination ” and also use brand name Steris healthcare……. H1 How works……H2 Why its important …….H2 Key Benefits of ……….H3 What are the benefits …….H2 Side effects………H3 Serious Side Effects Of ……….H3 Available Substitute For ……….H2 Dosage Guidelines For …..H2 Precautions & Warnings: …..H2 with using and also Mechanism to action also with composition“gliclazide and dapagliflozin combination” Target Buyer intent INDICATIONS, EFFICACY AND CLINICAL EVIDENCE keywords”” : Conclusion: keep conclusion and Frequently Asked Questions 1 Is it safe to take gliclazide and dapagliflozin together? 2 What are the benefits of taking gliclazide and dapagliflozin concurrently? 3 Which pharmacies offer combined treatment options involving gliclazide and dapagliflozin? 4 Where can I find a doctor specializing in diabetes management who prescribes this combination? 5 Where can I buy gliclazide and dapagliflozin in one prescription? 6 Which pharmacies offer combined treatment options involving gliclazide and dapagliflozin?\n\nFor Further More Information: \n\nMail Us: contact@sterispharma.com or info@sterispharma.com\n\nCall Now: +918824175417, +919982524671\n\nBuy Now\n\nBelow is SEO-friendly, GEO-optimized, buyer-intent content for your product page targeting “gliclazide and dapagliflozin combination” and branded as GLICLAGLAZE DAPA 60-10 from Steris Healthcare.\n\nGliclazide and Dapagliflozin Combination – Complete Guide to GLICLAGLAZE DAPA 60-10 by Steris Healthcare\nGliclazide and Dapagliflozin Combination – Complete Guide to GLICLAGLAZE DAPA 60-10 by Steris Healthcare\n\nDiabetes mellitus is one of the most common chronic metabolic disorders affecting millions of people worldwide. Effective blood sugar management requires a comprehensive treatment approach that helps control glucose levels, reduce complications, and improve overall quality of life. The gliclazide and dapagliflozin combination has emerged as an effective therapeutic option for patients with Type 2 Diabetes Mellitus (T2DM) who require better glycemic control.\n\nGLICLAGLAZE DAPA 60-10, developed by Steris Healthcare, combines the proven efficacy of Gliclazide 60 mg Sustained Release and Dapagliflozin 10 mg to provide dual-action blood glucose control. This innovative combination works through complementary mechanisms to help diabetic patients achieve target blood sugar levels effectively.\n\nThis detailed guide covers the mechanism of action, indications, benefits, dosage guidelines, precautions, efficacy, clinical evidence, side effects, and frequently asked questions regarding the gliclazide and dapagliflozin combination.\n\nHow Gliclazide and Dapagliflozin Combination Works\n\nThe gliclazide and dapagliflozin combination utilizes two distinct yet complementary mechanisms to lower blood glucose levels.\n\nGliclazide Mechanism of Action\n\nGliclazide belongs to the sulfonylurea class of antidiabetic medications. It stimulates the pancreatic beta cells to release insulin, helping the body reduce elevated blood sugar levels.\n\nKey actions include:\n\nIncreases insulin secretion from the pancreas\nImproves glucose utilization\nReduces fasting blood glucose\nEnhances post-meal glucose control\nHelps maintain long-term glycemic stability\nDapagliflozin Mechanism of Action\n\nDapagliflozin belongs to the SGLT2 (Sodium-Glucose Cotransporter-2) inhibitor class.\n\nIt works by:\n\nBlocking glucose reabsorption in the kidneys\nIncreasing glucose excretion through urine\nReducing blood sugar independently of insulin\nPromoting mild weight reduction\nSupporting cardiovascular and renal protection\nCombined Mechanism of Action\n\nWhen combined, Gliclazide and Dapagliflozin provide:\n\nIncreased insulin secretion\nReduced renal glucose reabsorption\nBetter fasting and postprandial glucose control\nLower HbA1c levels\nImproved metabolic outcomes\n\nThis dual-action approach makes GLICLAGLAZE DAPA 60-10 a highly effective treatment for Type 2 Diabetes Mellitus.\n\nWhy Its Important\n\nManaging diabetes effectively is essential to prevent serious complications such as:\n\nHeart disease\nStroke\nKidney damage\nNerve damage\nVision loss\nDiabetic foot complications\n\nThe gliclazide and dapagliflozin combination is important because it addresses multiple aspects of blood sugar regulation while offering additional metabolic and cardiovascular benefits.\n\nFor patients whose diabetes remains uncontrolled with single-drug therapy, combination treatment provides enhanced glucose management and improved treatment outcomes.\n\nKey Benefits of Gliclazide and Dapagliflozin Combination\n\nGLICLAGLAZE DAPA 60-10 offers several significant benefits for diabetic patients.\n\nBetter Blood Sugar Control\n\nThe combination effectively lowers fasting and post-meal blood glucose levels.\n\nSignificant HbA1c Reduction\n\nClinical studies demonstrate meaningful reductions in HbA1c levels, helping patients achieve glycemic targets.\n\nWeight Management Support\n\nDapagliflozin promotes urinary glucose excretion, which may contribute to modest weight loss.\n\nReduced Risk of Diabetes Complications\n\nConsistent glycemic control lowers the risk of long-term diabetic complications.\n\nCardiovascular Benefits\n\nDapagliflozin has demonstrated cardiovascular protective effects in high-risk diabetic patients.\n\nRenal Protection\n\nThe medication supports kidney health and may slow progression of diabetic kidney disease.\n\nConvenient Once-Daily Dosing\n\nThe formulation enhances patient compliance through simple administration.\n\nWhat Are the Benefits of Gliclazide and Dapagliflozin Combination?\n\nPatients taking GLICLAGLAZE DAPA 60-10 may experience:\n\nImproved glycemic control\nBetter insulin utilization\nLower HbA1c values\nEnhanced metabolic function\nReduced fasting blood sugar\nBetter postprandial glucose management\nWeight management support\nImproved cardiovascular outcomes\nRenal protective effects\nIncreased treatment adherence\nIndications of Gliclazide and Dapagliflozin Combination\n\nGLICLAGLAZE DAPA 60-10 is indicated for:\n\nType 2 Diabetes Mellitus\n\nUsed in adults when diet, exercise, and monotherapy do not adequately control blood glucose.\n\nInadequate Glycemic Control\n\nRecommended for patients requiring intensified diabetes treatment.\n\nLong-Term Diabetes Management\n\nSupports sustained blood glucose control and prevention of complications.\n\nPatients with Cardiovascular Risk Factors\n\nMay provide additional cardiovascular benefits alongside glycemic management.\n\nEfficacy and Clinical Evidence\n\nSeveral clinical studies support the effectiveness of combining sulfonylureas such as Gliclazide with SGLT2 inhibitors like Dapagliflozin.\n\nHbA1c Reduction\n\nClinical trials demonstrate:\n\nSignificant reductions in HbA1c levels\nImproved fasting plasma glucose\nEnhanced postprandial glucose control\nWeight Reduction\n\nDapagliflozin contributes to calorie loss through urinary glucose excretion, leading to modest weight reduction.\n\nCardiovascular Outcomes\n\nResearch indicates that SGLT2 inhibitors may reduce hospitalization for heart failure and improve cardiovascular outcomes.\n\nRenal Outcomes\n\nStudies have shown benefits in slowing progression of diabetic kidney disease and improving renal function markers.\n\nThese findings make the gliclazide and dapagliflozin combination a valuable therapeutic option for comprehensive diabetes management.\n\nSide Effects of Gliclazide and Dapagliflozin Combination\n\nLike all medications, GLICLAGLAZE DAPA 60-10 may cause side effects.\n\nCommon side effects include:\n\nHeadache\nDizziness\nFrequent urination\nIncreased thirst\nNausea\nFatigue\nMild urinary tract infections\nGenital fungal infections\nLow blood sugar (hypoglycemia)\n\nMost side effects are mild and manageable.\n\nSerious Side Effects Of Gliclazide and Dapagliflozin Combination\n\nAlthough uncommon, serious side effects may include:\n\nSevere hypoglycemia\nDiabetic ketoacidosis\nSevere dehydration\nAcute kidney injury\nSerious urinary tract infections\nAllergic reactions\nSevere skin reactions\n\nSeek immediate medical attention if serious symptoms occur.\n\nAvailable Substitute For Gliclazide and Dapagliflozin Combination\n\nAlternative antidiabetic combinations may include:\n\nMetformin + Dapagliflozin\nSitagliptin + Dapagliflozin\nGliclazide + Metformin\nGlimepiride + Dapagliflozin\nEmpagliflozin-based combinations\n\nThe choice of therapy should always be determined by a healthcare professional based on individual patient needs.\n\nDosage Guidelines For Gliclazide and Dapagliflozin Combination\nRecommended Dose\n\nTake GLICLAGLAZE DAPA 60-10 exactly as prescribed by your physician.\n\nAdministration Instructions\nUsually taken once daily\nSwallow the tablet whole\nDo not crush or chew sustained-release tablets\nTake with or after food if advised\nMaintain adequate hydration\nMissed Dose\n\nIf a dose is missed:\n\nTake it as soon as remembered\nSkip if close to the next scheduled dose\nDo not double the dose\nOverdose\n\nSeek immediate medical attention in case of overdose.\n\nPrecautions & Warnings: Gliclazide and Dapagliflozin Combination\nMonitor Blood Sugar Regularly\n\nFrequent blood glucose monitoring helps optimize treatment outcomes.\n\nRisk of Hypoglycemia\n\nPatients should recognize symptoms such as:\n\nSweating\nTremors\nHunger\nConfusion\nDizziness\nMaintain Hydration\n\nDapagliflozin increases urinary glucose excretion and may increase fluid loss.\n\nKidney Function Monitoring\n\nRegular renal function assessments are recommended.\n\nLiver Function Monitoring\n\nPeriodic liver function evaluation may be necessary.\n\nPregnancy and Breastfeeding\n\nConsult a healthcare professional before use during pregnancy or lactation.\n\nAlcohol Consumption\n\nAlcohol may increase the risk of hypoglycemia and should be used cautiously.\n\nElderly Patients\n\nAdditional monitoring may be required due to increased sensitivity to treatment effects.\n\nWhy Choose GLICLAGLAZE DAPA 60-10 from Steris Healthcare?\n\nSteris Healthcare is committed to providing high-quality pharmaceutical products that support better patient outcomes.\n\nBenefits include:\n\nHigh manufacturing standards\nReliable quality assurance\nEffective diabetes management solution\nAdvanced combination therapy\nImproved patient compliance\nTrusted healthcare support\n\nGLICLAGLAZE DAPA 60-10 reflects Steris Healthcare’s dedication to innovation and excellence in diabetes care.\n\nConclusion\n\nThe gliclazide and dapagliflozin combination found in GLICLAGLAZE DAPA 60-10 offers a comprehensive and effective approach to Type 2 Diabetes Mellitus management. By combining the insulin-stimulating effects of Gliclazide with the glucose-excreting action of Dapagliflozin, this therapy provides superior blood sugar control, improved HbA1c reduction, cardiovascular support, renal protection, and enhanced patient convenience.\n\nFor patients seeking better glycemic control and long-term diabetes management, GLICLAGLAZE DAPA 60-10 from Steris Healthcare represents a scientifically supported and clinically effective treatment option.\n\nBuy Now\n\nFor product inquiries, bulk orders, franchise opportunities, and distribution partnerships:\n\nMail Us: contact@sterispharma.com or info@sterispharma.com\n\nCall Now: +91 8824175417, +91 9982524671\n\nBuy Now: Contact Steris Healthcare for product availability and ordering information.\n\nFrequently Asked Questions (FAQs)\n1. Is it safe to take gliclazide and dapagliflozin together?\n\nYes. Under medical supervision, the combination is considered safe and effective for managing Type 2 Diabetes Mellitus.\n\n2. What are the benefits of taking gliclazide and dapagliflozin concurrently?\n\nThe combination offers improved blood sugar control, HbA1c reduction, weight management support, cardiovascular benefits, and renal protection.\n\n3. Which pharmacies offer combined treatment options involving gliclazide and dapagliflozin?\n\nMany retail pharmacies, hospital pharmacies, and authorized pharmaceutical distributors stock gliclazide and dapagliflozin combination products. Availability may vary by location.\n\n4. Where can I find a doctor specializing in diabetes management who prescribes this combination?\n\nEndocrinologists, diabetologists, and experienced physicians commonly prescribe this combination for Type 2 Diabetes management.\n\n5. Where can I buy gliclazide and dapagliflozin in one prescription?\n\nYou can obtain the medication through a valid prescription from a registered healthcare professional and purchase it from authorized pharmacies.\n\n6. Which pharmacies offer combined treatment options involving gliclazide and dapagliflozin?\n\nLicensed pharmacies, diabetes specialty centers, and authorized pharmaceutical distributors often provide combination antidiabetic therapies, including GLICLAGLAZE DAPA 60-10.\n\ncreate 3d image without changing product image\nEdit\ncreate 3d image without changing product image please regenerate again\nEdit\nThis is my product page H1 Title “ Benfotiamine Mecobalamin,Pyridoxine Hydrochloride Folic Acid,Inositol & Alpha Lipoic Acid Capsules” generate complete as a buyer intent reading content on this targted keyword. content must between 1000- 1200 words \nBenfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules – Complete Guide for Nerve Health and Diabetic Neuropathy Support\n\nMaintaining healthy nerves is essential for overall well-being, especially for individuals living with diabetes, nutritional deficiencies, metabolic disorders, and nerve-related complications. Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules are scientifically formulated to provide comprehensive nutritional support for nerve health, improve nerve function, and help manage symptoms associated with diabetic neuropathy and peripheral nerve disorders.\n\nThis advanced combination contains essential neurotropic vitamins and antioxidants that work together to nourish damaged nerves, improve nerve conduction, reduce oxidative stress, and support overall neurological health. These capsules are widely prescribed by healthcare professionals for patients experiencing tingling, numbness, burning sensations, nerve pain, and vitamin B deficiencies.\n\nWhether you are searching for an effective solution for diabetic neuropathy or looking to support long-term nerve health, Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules offer a comprehensive approach to neurological wellness.\n\nWhat Are Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules?\n\nThese capsules combine six powerful ingredients known for their nerve-protective and restorative properties:\n\nBenfotiamine\nMecobalamin (Methylcobalamin)\nPyridoxine Hydrochloride (Vitamin B6)\nFolic Acid (Vitamin B9)\nInositol\nAlpha Lipoic Acid\n\nTogether, these ingredients help support healthy nerve function, improve metabolic processes, and protect nerve tissues from damage caused by oxidative stress and elevated blood sugar levels.\n\nHow Do Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules Work?\n\nThe effectiveness of this formulation lies in its multi-dimensional mechanism of action.\n\nBenfotiamine\n\nBenfotiamine is a fat-soluble derivative of Vitamin B1 that offers superior absorption.\n\nIt helps:\n\nProtect nerves from glucose-induced damage\nImprove nerve conductivity\nReduce diabetic complications\nSupport healthy metabolism\nMecobalamin\n\nMecobalamin is an active form of Vitamin B12 that plays a critical role in nerve regeneration.\n\nBenefits include:\n\nRepairing damaged nerve cells\nSupporting myelin sheath formation\nEnhancing nerve signal transmission\nReducing neuropathic symptoms\nPyridoxine Hydrochloride\n\nVitamin B6 supports neurological and metabolic functions.\n\nIt helps:\n\nMaintain healthy nerve cells\nImprove neurotransmitter production\nSupport brain and nervous system function\nFolic Acid\n\nFolic Acid contributes to:\n\nDNA synthesis\nRed blood cell production\nNerve cell development\nHomocysteine reduction\nInositol\n\nInositol assists in:\n\nNerve signaling pathways\nCellular communication\nMetabolic regulation\nNeurological function support\nAlpha Lipoic Acid\n\nAlpha Lipoic Acid is a potent antioxidant.\n\nIt helps:\n\nNeutralize free radicals\nReduce oxidative stress\nImprove nerve blood flow\nRelieve symptoms of diabetic neuropathy\nKey Benefits of Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules\n\nThis unique formulation offers multiple health benefits.\n\nSupports Nerve Regeneration\n\nThe combination promotes repair and regeneration of damaged nerve tissues.\n\nHelps Manage Diabetic Neuropathy\n\nMany diabetic patients experience:\n\nTingling sensations\nBurning feet\nNumbness\nSharp nerve pain\n\nThese capsules help manage such symptoms effectively.\n\nReduces Oxidative Stress\n\nAlpha Lipoic Acid protects nerves from oxidative damage caused by free radicals.\n\nImproves Nerve Conduction\n\nMecobalamin and Benfotiamine help restore healthy nerve signaling pathways.\n\nEnhances Energy Metabolism\n\nB-complex vitamins improve cellular energy production and metabolic efficiency.\n\nSupports Brain and Cognitive Function\n\nEssential vitamins support neurological health and mental performance.\n\nHelps Prevent Vitamin Deficiencies\n\nProvides important nutrients often deficient in diabetic and elderly patients.\n\nWhy Doctors Recommend Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules\n\nHealthcare professionals commonly prescribe this combination because it addresses the underlying nutritional and oxidative factors contributing to nerve damage.\n\nDoctors often recommend these capsules for:\n\nDiabetic neuropathy\nPeripheral neuropathy\nVitamin B12 deficiency\nNerve pain management\nNutritional supplementation\nNeurological disorders\nRecovery from nerve injuries\n\nThe synergistic action of these ingredients offers broader therapeutic benefits than single-nutrient supplements.\n\nIndications\n\nBenfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules are commonly indicated for:\n\nDiabetic Neuropathy\n\nHelps reduce symptoms associated with diabetes-related nerve damage.\n\nPeripheral Neuropathy\n\nSupports nerve health in patients experiencing nerve dysfunction.\n\nVitamin B Complex Deficiencies\n\nProvides nutritional support for individuals with inadequate vitamin intake.\n\nNerve Pain\n\nHelps manage neuropathic discomfort and sensory disturbances.\n\nMetabolic Neuropathy\n\nSupports patients affected by metabolic conditions impacting nerve function.\n\nNeurological Support\n\nUseful in maintaining healthy nervous system function.\n\nWho Should Consider These Capsules?\n\nThese capsules may benefit:\n\nIndividuals with diabetes\nPatients experiencing numbness or tingling\nElderly individuals with nerve weakness\nPeople recovering from neurological disorders\nIndividuals with vitamin B deficiencies\nPatients with chronic nerve pain\n\nA healthcare professional can determine if this supplement is appropriate based on individual medical needs.\n\nDosage and Administration\n\nAlways take Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules as directed by your healthcare provider.\n\nGeneral Guidelines\nUsually taken once daily or as prescribed\nSwallow the capsule whole with water\nPreferably taken after meals\nFollow the recommended dosage schedule\n\nDo not exceed the prescribed dose without medical advice.\n\nPossible Side Effects\n\nMost patients tolerate these capsules well. However, some individuals may experience mild side effects.\n\nCommon side effects may include:\n\nNausea\nStomach discomfort\nMild headache\nDizziness\nBloating\nSkin rash\nAllergic reactions\n\nThese side effects are generally temporary and manageable.\n\nPrecautions and Warnings\n\nBefore taking these capsules, consider the following precautions:\n\nConsult Your Doctor If You Have:\nKidney disease\nLiver disorders\nSevere diabetes complications\nAllergies to any ingredient\nPregnancy and Breastfeeding\n\nUse only under medical supervision during pregnancy and lactation.\n\nDrug Interactions\n\nInform your doctor about:\n\nAntidiabetic medications\nAnticonvulsants\nVitamin supplements\nPrescription medications\nRegular Monitoring\n\nPatients with diabetes should continue monitoring blood glucose levels as advised.\n\nWhy Choose This Advanced Nerve Health Formula?\n\nThe combination of Benfotiamine, Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol, and Alpha Lipoic Acid provides comprehensive support through multiple mechanisms.\n\nKey advantages include:\n\nMulti-nutrient nerve support\nEnhanced antioxidant protection\nImproved nerve regeneration\nBetter diabetic neuropathy management\nConvenient single-capsule formulation\nLong-term neurological health benefits\n\nThis makes it an excellent choice for individuals seeking a scientifically formulated nerve support supplement.\n\nConclusion\n\nBenfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules represent a comprehensive solution for supporting nerve health, managing diabetic neuropathy, and addressing nutritional deficiencies that affect neurological function. The synergistic combination of neurotropic vitamins and powerful antioxidants helps repair damaged nerves, improve nerve conduction, reduce oxidative stress, and promote overall neurological wellness.\n\nFor individuals experiencing nerve pain, numbness, tingling sensations, or diabetic neuropathy symptoms, these capsules offer an effective and clinically trusted option. When used under medical supervision, they can play a valuable role in maintaining healthy nerve function and improving quality of life.\n\nFrequently Asked Questions (FAQs)\n1. What are Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules used for?\n\nThey are primarily used to support nerve health, manage diabetic neuropathy, and treat vitamin B deficiencies.\n\n2. Can these capsules help with diabetic neuropathy?\n\nYes. The combination is commonly prescribed to help reduce symptoms such as tingling, numbness, burning sensations, and nerve pain associated with diabetic neuropathy.\n\n3. How long does it take to see results?\n\nResults vary depending on the severity of nerve damage and individual health conditions. Consistent use as prescribed is important.\n\n4. Are these capsules safe for long-term use?\n\nWhen taken under medical supervision, they are generally considered safe for long-term nutritional and neurological support.\n\n5. Can non-diabetic patients take these capsules?\n\nYes. They may also be prescribed for vitamin deficiencies, peripheral neuropathy, and other nerve-related conditions.\n\n6. Do these capsules require a prescription?\n\nAvailability may vary by region, but it is always recommended to use them under the guidance of a healthcare professional.", "price": 390.0, "discountamount": 117.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2435, "imageuri": "https://productimages.withfloats.com/actual/6a1ec0fefe6140386d7a9074.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a1ec0fefe6140386d7a9074.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-06-02T11:39:39.761Z", "updatedon": "2026-06-04T07:08:32.501Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//benfotiamine-mecobalamin-pyridoxine-hydrochloride-folic-acid-inositol-alpha-lipoic-acid-capsules/2435", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NUTRIDIAB PN", "category": "NEUROLOGY RANGE", "tags": [ "Benfotiamine,Mecobalamin,Pyridoxine Hydrochloride,Folic Acid,Inositol & Alpha Lipoic Acid Capsules", "Methylcobalamin alpha lipoic acid Pyridoxine Folic Acid Benfotiamine", "Benfotiamine Mecobalamin Pyridoxine Hydrochloride Folic Acid Inositol Alpha Lipoic Acid Capsules", "Buy Benfotiamine Mecobalamin Alpha Lipoic Acid Capsules Online", "Buy Benfotiamine Mecobalamin Alpha Lipoic Acid Capsules Online", "Diabetic Neuropathy Treatment Capsules", "Benfotiamine and Mecobalamin Capsules for Nerve Pain", "Alpha Lipoic Acid Capsules for Diabetic Neuropathy", "Vitamin B Complex and Alpha Lipoic Acid Capsules", "Benfotiamine Mecobalamin Capsules Product Image", "Best Capsules for Diabetic Nerve Damage", "Nerve Regeneration and Nerve Support Capsules", "Vitamin B12 and Alpha Lipoic Acid Capsules", "Nerve Strengthening Capsules with Benfotiamine", "Benfotiamine Mecobalamin Alpha Lipoic Acid Capsules for Neuropathy" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a06f0051c45b26e830ddf29", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "dapagliflozin 10 vildagliptin 100 metformin 1000", "description": "Managing type 2 diabetes effectively requires the right combination of medicines, healthy eating habits, and an active lifestyle. Dapagliflozin 10 mg, Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets is a powerful triple-combination anti-diabetic medication designed to help control blood sugar levels in adults suffering from type 2 diabetes mellitus. This advanced formulation combines three clinically trusted medicines in one tablet to improve glycemic control and support long-term diabetic management.\n\nThis combination is commonly prescribed when blood sugar levels are not adequately controlled with a single medicine or dual therapy. It helps patients achieve better glucose regulation while reducing the risk of diabetes-related complications.\n\nWhat is Dapagliflozin 10 mg, Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets?\n\nDapagliflozin 10 mg, Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets is a combination medication used for the treatment of Type 2 Diabetes Mellitus. It contains:\n\nDapagliflozin 10 mg\nVildagliptin SR 100 mg\nMetformin SR 1000 mg\n\nEach ingredient works through a different mechanism to provide comprehensive blood sugar control.\n\nThis medicine is generally recommended along with proper diet and exercise to improve overall diabetic management and reduce insulin resistance.\n\nComposition of Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg Tablets\n1. Dapagliflozin 10 mg\n\nDapagliflozin belongs to the SGLT2 inhibitor class of medicines. It works by removing excess glucose from the body through urine. This helps lower blood sugar levels naturally.\n\n2. Vildagliptin SR 100 mg\n\nVildagliptin is a DPP-4 inhibitor that increases incretin hormone levels in the body. These hormones help regulate insulin secretion and reduce glucose production by the liver.\n\n3. Metformin SR 1000 mg\n\nMetformin is one of the most trusted anti-diabetic medicines worldwide. It reduces glucose production in the liver and improves insulin sensitivity in the body.\n\nThe sustained-release (SR) formulation ensures gradual release of medicine for long-lasting action and better patient compliance.\n\nHow Do Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg Tablets Work?\n\nThis triple combination provides multidimensional control over blood sugar levels.\n\nDapagliflozin Works By:\nRemoving excess sugar through urine\nLowering fasting blood glucose\nSupporting weight management\nVildagliptin Works By:\nIncreasing insulin release after meals\nReducing glucagon secretion\nImproving pancreatic function\nMetformin Works By:\nReducing liver glucose production\nImproving insulin sensitivity\nLowering intestinal glucose absorption\n\nTogether, these medicines help maintain stable blood glucose levels throughout the day.\n\nBenefits of Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg Tablets\nEffective Blood Sugar Control\n\nThe combination targets multiple pathways involved in diabetes, helping achieve better glycemic control.\n\nReduced Risk of Diabetes Complications\n\nProper diabetes management lowers the risk of:\n\nKidney problems\nNerve damage\nHeart disease\nVision complications\nWeight Management Support\n\nDapagliflozin helps remove excess glucose, which may contribute to mild weight reduction in some patients.\n\nImproved Insulin Sensitivity\n\nMetformin enhances insulin utilization by body tissues.\n\nBetter Patient Compliance\n\nThree medicines in a single tablet reduce pill burden and simplify treatment.\n\nSustained Release Formula\n\nThe SR formulation provides extended therapeutic action and minimizes fluctuations in blood sugar levels.\n\nUses of Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg Tablets\n\nThis medicine is mainly prescribed for:\n\nType 2 Diabetes Mellitus\nUncontrolled diabetes despite dual therapy\nPatients requiring triple-drug glucose control\nImproving HbA1c levels\nManaging post-meal blood sugar spikes\n\nIt is generally not recommended for type 1 diabetes unless specifically advised by a healthcare professional.\n\nWho Can Take This Medicine?\n\nDapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg tablets may be suitable for:\n\nAdults diagnosed with type 2 diabetes\nPatients with insulin resistance\nIndividuals requiring combination diabetic therapy\nPatients seeking convenient once-daily diabetic medication\n\nAlways use this medicine under medical supervision.\n\nDosage and Administration\nTake the tablet exactly as prescribed by your doctor.\nUsually taken once daily with meals.\nSwallow the tablet whole with water.\nDo not crush or chew sustained-release tablets.\nFollow dietary recommendations for best results.\n\nDosage may vary depending on blood sugar levels and patient response.\n\nPossible Side Effects\n\nLike all medicines, Dapagliflozin 10 mg, Vildagliptin SR 100 mg And Metformin SR 1000 mg tablets may cause some side effects.\n\nCommon Side Effects\nNausea\nDiarrhea\nFrequent urination\nHeadache\nStomach discomfort\nWeakness\nLess Common Side Effects\nUrinary tract infections\nGenital fungal infections\nDizziness\nLow blood sugar (especially with other anti-diabetic medicines)\nSerious Side Effects\n\nSeek immediate medical attention if you experience:\n\nSevere dehydration\nDifficulty breathing\nSevere abdominal pain\nSigns of allergic reaction\nPersistent vomiting\n\nMost side effects are mild and improve as the body adjusts to the medicine.\n\nPrecautions and Warnings\n\nBefore taking this medicine, inform your doctor if you have:\n\nKidney disease\nLiver disorders\nHeart disease\nHistory of pancreatitis\nDehydration issues\nAlcohol dependence\nImportant Precautions\nStay hydrated while taking dapagliflozin.\nMonitor blood sugar regularly.\nAvoid excessive alcohol consumption.\nFollow a diabetic-friendly diet.\n\nPregnant and breastfeeding women should consult a doctor before use.\n\nDrug Interactions\n\nThis medicine may interact with:\n\nInsulin\nSulfonylureas\nDiuretics\nBlood pressure medicines\nCorticosteroids\n\nAlways inform your doctor about all medications and supplements you are taking.\n\nStorage Instructions\nStore in a cool and dry place.\nKeep away from direct sunlight and moisture.\nStore below recommended room temperature.\nKeep out of reach of children.\n\nProper storage ensures medicine effectiveness and safety.\n\nWhy Choose Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg Tablets?\n\nThis advanced antidiabetic combination offers:\n\nTriple-action diabetes management\nLong-lasting blood sugar control\nConvenient dosing\nImproved patient adherence\nComprehensive glycemic regulation\n\nIt is widely preferred by healthcare professionals for patients requiring strong and reliable diabetic treatment.\n\nLifestyle Tips for Better Diabetes Management\n\nAlong with medication, patients should:\n\nMaintain a balanced diabetic diet\nExercise regularly\nMonitor blood glucose levels\nStay hydrated\nAvoid sugary foods\nFollow regular medical checkups\n\nHealthy lifestyle changes significantly improve treatment outcomes.\n\nFrequently Asked Questions\nIs Dapagliflozin 10 mg, Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets safe for long-term use?\n\nYes, when taken under medical supervision, it is generally considered safe for long-term diabetes management.\n\nCan this medicine help reduce HbA1c levels?\n\nYes, this combination is effective in lowering HbA1c and maintaining blood sugar control.\n\nDoes this medicine cause weight gain?\n\nDapagliflozin may support mild weight reduction in some patients.\n\nCan I stop the medicine once sugar levels improve?\n\nDo not stop taking the medicine without consulting your doctor.\n\nIs this medicine suitable for elderly patients?\n\nIt may be prescribed to elderly patients after proper medical evaluation.\n\nConclusion\n\nDapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg tablets are a highly effective triple-combination therapy for managing type 2 diabetes mellitus. By combining the benefits of dapagliflozin, vildagliptin, and metformin SR, this medicine provides comprehensive blood sugar control, improves insulin sensitivity, and helps reduce diabetes-related complications.", "price": 375.0, "discountamount": 113.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2422, "imageuri": "https://productimages.withfloats.com/actual/6a06f00b91493d06f6e7fcdf.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a06f00b91493d06f6e7fcdf.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-05-15T10:05:57.462Z", "updatedon": "2026-06-05T07:31:14.082Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//dapagliflozin-10-vildagliptin-100-metformin-1000/2422", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "DAPAVILDA MET 10/100/1000", "category": "DIABETIC RANGE", "tags": [ "dapagliflozin 10 vildagliptin 100 metformin 1000", "dapagliflozin vildagliptin metformin", "dapagliflozin vildagliptin metformin combination", "dapagliflozin vildagliptin metformin 1000", "Dapagliflozin + Vildagliptin + Metformin Tablets", "Buy Dapagliflozin + Vildagliptin + Metformin Tablets Online", "Type 2 Diabetes Treatment Tablets", "Blood Sugar Control Medicine with Dapagliflozin, Vildagliptin & Metformin", "Triple Combination Anti-Diabetic Tablets", "Best Diabetes Control Tablets for Type 2 Diabetes", "Prescription Anti-Diabetic Medicine Tablets", "Dapagliflozin 10 mg Vildagliptin 100 mg Metformin 1000 mg Product Image", "Premium Quality Diabetic Care Tablets", "Combination Diabetes Medicine for Glycemic Control", "Type 2 Diabetes Management Tablets Online", "Advanced Blood Sugar Control Tablets", "Dapagliflozin Vildagliptin Metformin Tablets Supplier in India", "Dapagliflozin Vildagliptin Metformin Tablets Manufacturer in India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69afcdd7726d81b4833817a9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "metformin linagliptin", "description": "Advanced Combination Therapy with Metformin and Linagliptin for Effective Blood Sugar Control\n\nManaging type 2 diabetes requires consistent care, the right medication, and lifestyle management to maintain healthy blood glucose levels. Modern diabetes treatment often uses combination therapies that work through different mechanisms to provide better control and long-term health benefits. LINALIGOLD M 2.5/1000 is a scientifically formulated anti-diabetic medication that combines Metformin (1000 mg) and Linagliptin (2.5 mg) to help manage blood sugar levels effectively in adults with type 2 diabetes mellitus.\n\nThis dual-action tablet is designed to improve glycemic control when diet and exercise alone are not sufficient. By targeting different pathways involved in glucose regulation, LINALIGOLD M 2.5/1000 helps maintain stable blood sugar levels, supports metabolic health, and reduces the risk of diabetes-related complications.\n\nProduct Description\n\nLINALIGOLD M 2.5/1000 is a combination anti-diabetic medication that brings together two well-established drugs used in diabetes management: Metformin, a biguanide that reduces glucose production in the liver and improves insulin sensitivity, and Linagliptin, a DPP-4 inhibitor that enhances the body’s natural ability to regulate blood sugar levels.\n\nThis powerful combination works synergistically to control blood glucose levels throughout the day. While Metformin helps decrease the amount of sugar released into the bloodstream from the liver, Linagliptin increases the activity of incretin hormones, which stimulate insulin release when blood sugar levels are high.\n\nLINALIGOLD M 2.5/1000 is commonly prescribed for patients with type 2 diabetes mellitus who require improved glycemic control and who may not achieve adequate results with a single medication.\n\nKey Ingredients and Their Role\nMetformin (1000 mg)\n\nMetformin is one of the most widely used medications for the treatment of type 2 diabetes. It works primarily by:\n\nReducing glucose production in the liver\n\nImproving the body's sensitivity to insulin\n\nIncreasing glucose uptake by muscle cells\n\nReducing absorption of glucose from the intestines\n\nThese actions help lower fasting and post-meal blood sugar levels while supporting overall metabolic balance.\n\nLinagliptin (2.5 mg)\n\nLinagliptin belongs to a class of medications known as DPP-4 inhibitors. It works by increasing levels of incretin hormones in the body, which help regulate blood glucose levels. Its actions include:\n\nStimulating insulin release after meals\n\nReducing excessive glucose production by the liver\n\nLowering postprandial (after meal) blood sugar levels\n\nSupporting natural glucose regulation without causing sudden drops in blood sugar\n\nTogether, these two ingredients provide a comprehensive approach to diabetes management.\n\nUses of LINALIGOLD M 2.5/1000\n\nLINALIGOLD M 2.5/1000 is primarily used for the treatment and management of type 2 diabetes mellitus in adults. It helps maintain proper blood sugar levels and supports long-term metabolic health.\n\n1. Management of Type 2 Diabetes\n\nThis medication is prescribed to help control blood sugar levels in individuals diagnosed with type 2 diabetes when lifestyle modifications alone are not enough.\n\n2. Improvement of Glycemic Control\n\nThe dual mechanism of action helps regulate both fasting and post-meal blood glucose levels, improving overall glycemic control.\n\n3. Prevention of Diabetes Complications\n\nProper management of blood sugar levels helps reduce the risk of diabetes-related complications such as nerve damage, kidney problems, eye disorders, and cardiovascular disease.\n\n4. Support for Insulin Sensitivity\n\nMetformin helps improve the body's response to insulin, making it easier for cells to utilize glucose efficiently.\n\nKey Benefits of LINALIGOLD M 2.5/1000\n1. Dual Mechanism for Better Blood Sugar Control\n\nThe combination of Metformin and Linagliptin provides a two-way approach to controlling blood glucose levels by addressing multiple pathways involved in glucose metabolism.\n\n2. Helps Maintain Stable Blood Sugar Levels\n\nLINALIGOLD M 2.5/1000 helps regulate blood sugar throughout the day, including after meals when glucose levels tend to spike.\n\n3. Supports Natural Insulin Activity\n\nLinagliptin enhances the body's natural insulin response without forcing the pancreas to overwork.\n\n4. Reduces Risk of Blood Sugar Spikes\n\nBy controlling glucose production in the liver and improving insulin efficiency, the medication helps prevent sudden increases in blood sugar.\n\n5. Improves Overall Metabolic Health\n\nRegular use, along with proper diet and exercise, supports better metabolic balance and energy utilization in the body.\n\n6. Convenient Combination Therapy\n\nInstead of taking multiple medications separately, this fixed-dose combination simplifies diabetes management and improves treatment adherence.\n\n7. Lower Risk of Hypoglycemia\n\nCompared with some other diabetes medications, Linagliptin generally carries a lower risk of causing dangerously low blood sugar levels when used appropriately.\n\nHow to Use LINALIGOLD M 2.5/1000\n\nLINALIGOLD M 2.5/1000 should be taken exactly as prescribed by a healthcare professional.\n\nGeneral usage guidelines include:\n\nTake the tablet with food to reduce stomach discomfort.\n\nSwallow the tablet whole with water; do not crush or chew unless advised.\n\nFollow the dosage and schedule recommended by your doctor.\n\nMaintain a healthy diet and regular physical activity for optimal results.\n\nConsistent use is important for maintaining stable blood sugar levels.\n\nPossible Side Effects\n\nLike all medications, LINALIGOLD M 2.5/1000 may cause side effects in some individuals, although not everyone experiences them. Most side effects are mild and temporary as the body adjusts to the medication.\n\nCommon side effects may include:\n\nNausea\n\nDiarrhea\n\nStomach discomfort\n\nLoss of appetite\n\nMild headache\n\nFatigue\n\nLess common but possible side effects include:\n\nUpper respiratory symptoms such as cough or sore throat\n\nMild skin reactions\n\nVitamin B12 deficiency with long-term use of metformin\n\nRare but serious side effects may include:\n\nSevere allergic reactions\n\nLactic acidosis (a rare but serious condition associated with metformin)\n\nPancreatitis in rare cases related to DPP-4 inhibitors\n\nIf symptoms such as severe abdominal pain, unusual weakness, breathing difficulty, or persistent vomiting occur, medical attention should be sought immediately.\n\nPrecautions\n\nBefore taking LINALIGOLD M 2.5/1000, it is important to consult a healthcare professional, especially if you have:\n\nKidney disease\n\nLiver problems\n\nHeart conditions\n\nHistory of pancreatitis\n\nSevere infections or dehydration\n\nAdditional precautions include:\n\nAvoid excessive alcohol consumption.\n\nInform your doctor about all medications you are currently taking.\n\nRegular blood sugar monitoring is recommended.\n\nLifestyle Recommendations for Better Results\n\nMedication works best when combined with healthy lifestyle practices. Patients using LINALIGOLD M 2.5/1000 are encouraged to:\n\nFollow a balanced diabetic-friendly diet\n\nEngage in regular physical activity\n\nMaintain a healthy body weight\n\nMonitor blood glucose levels regularly\n\nAttend routine medical checkups\n\nThese habits can significantly improve diabetes management and overall health.\n\nConclusion\nType 2 diabetes is a chronic condition that requires consistent and effective management to prevent long-term health complications. LINALIGOLD M 2.5/1000 offers a modern combination therapy that integrates the glucose-lowering effects of metformin with the incretin-enhancing action of Linagliptin, providing a comprehensive approach to blood sugar control.", "price": 154.0, "discountamount": 46.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2323, "imageuri": "https://productimages.withfloats.com/actual/69afcdd9ea5ba715c39c99dc.png", "tileimageuri": "https://productimages.withfloats.com/tile/69afcdd9ea5ba715c39c99dc.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-03-10T07:52:55.329Z", "updatedon": "2026-03-13T09:13:04.519Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//metformin-linagliptin/2323", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGOLD M 2.5/1000", "category": "DIABETIC RANGE", "tags": [ "metformin and linagliptin tablets for diabetes", "metformin linagliptin oral diabetes medication", "linagliptin 2.5 mg metformin 1000 mg tablet", "medicine for type 2 diabetes metformin linagliptin", "best medicine combination for type 2 diabetes", "blood sugar control medicine with metformin", "tablet for fasting and post meal sugar control", "how metformin linagliptin works for diabetes", "metformin linagliptin dosage for type 2 diabetes", "metformin linagliptin tablet price", "linagliptin metformin tablets wholesale price", "LINALIGOLD M metformin linagliptin tablet price", "LINALIGOLD M tablet for type 2 diabetes", "metformin linagliptin tablets india", "linagliptin metformin tablet manufacturer india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69a9837a9c219e2cff873568", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "dapagliflozin glimepiride metformin tablet", "description": "Composition: Dapagliflozin 10 mg + Glimepiride 2 mg + Metformin Hydrochloride 500 mg (Extended Release)\n\nManaging type 2 diabetes requires a balanced approach that includes proper medication, healthy lifestyle choices, and regular monitoring of blood sugar levels. Modern diabetes management often involves combination therapies that target blood glucose control through multiple mechanisms. One such effective combination medicine is GLIDAPAFLOZIN TRIO 2.\n\nThis medication contains three well-known antidiabetic agents—Dapagliflozin, Glimepiride, and Metformin Hydrochloride in an extended-release formulation. Together, these medicines work in different ways to help control blood sugar levels effectively in adults with type 2 diabetes.\n\nThis article provides a comprehensive overview of the product, its uses, benefits, possible side effects, and important information patients should know before using it.\n\nProduct Overview\n\nGLIDAPAFLOZIN TRIO 2 is a triple-combination oral antidiabetic tablet designed to help manage blood glucose levels in patients diagnosed with Type 2 Diabetes.\n\nEach tablet contains:\n\nDapagliflozin 10 mg\n\nGlimepiride 2 mg\n\nMetformin Hydrochloride 500 mg (Extended Release)\n\nThese ingredients work together to reduce high blood sugar levels through complementary mechanisms, helping patients achieve better glycemic control.\n\nCombination therapy like this is commonly recommended when a single medication alone is not sufficient to manage blood glucose levels.\n\nHow the Medicine Works\n\nThe three active ingredients in GLIDAPAFLOZIN TRIO 2 work through different pathways in the body.\n\n1. Dapagliflozin\n\nDapagliflozin belongs to a class of drugs known as SGLT2 inhibitors. It works by helping the kidneys remove excess glucose from the body through urine. This reduces blood sugar levels and may also provide additional cardiovascular and kidney benefits in some patients.\n\n2. Glimepiride\n\nGlimepiride stimulates the pancreas to release more insulin. Insulin is the hormone responsible for moving glucose from the bloodstream into cells where it can be used as energy.\n\n3. Metformin Hydrochloride (Extended Release)\n\nMetformin Hydrochloride helps lower blood sugar by reducing glucose production in the liver and improving insulin sensitivity in the body. The extended-release formulation ensures a steady release of the medicine over time, improving tolerance and effectiveness.\n\nTogether, these three medicines provide a comprehensive approach to blood sugar management.\n\nUses of GLIDAPAFLOZIN TRIO 2\n\nGLIDAPAFLOZIN TRIO 2 is primarily prescribed for the management of Type 2 Diabetes in adults.\n\nMain Uses\n\nBlood Sugar Control\nThe medication helps reduce high blood glucose levels in patients whose diabetes is not adequately controlled with diet, exercise, or single-drug therapy.\n\nImproving Insulin Function\nIt improves the body’s response to insulin and helps regulate glucose metabolism.\n\nPreventing Diabetes Complications\nProper blood sugar control reduces the risk of long-term complications such as nerve damage, kidney disease, vision problems, and cardiovascular issues.\n\nSupporting Weight and Metabolic Health\nThe presence of dapagliflozin may help some patients experience mild weight reduction and improved metabolic balance.\n\nKey Benefits\n\nThe combination of three effective antidiabetic agents offers several important benefits.\n\n1. Triple Mechanism Action\n\nThe medicine works through three complementary mechanisms, targeting multiple causes of high blood sugar.\n\n2. Better Glycemic Control\n\nPatients often achieve improved HbA1c levels compared to single-drug therapy.\n\n3. Reduced Risk of Long-Term Complications\n\nMaintaining controlled blood sugar levels helps prevent complications associated with diabetes.\n\n4. Convenient Single Tablet Therapy\n\nInstead of taking multiple medicines separately, patients can manage their treatment with a single tablet, improving medication adherence.\n\n5. Extended Release Technology\n\nThe extended-release formulation of Metformin Hydrochloride ensures gradual drug release, reducing stomach discomfort and improving patient tolerance.\n\n6. Improved Energy and Daily Functioning\n\nProper blood sugar control helps patients feel more energetic and maintain better overall health.\n\nPossible Side Effects\n\nLike all medications, GLIDAPAFLOZIN TRIO 2 may cause some side effects. However, not everyone experiences them.\n\nCommon Side Effects\n\nMild stomach discomfort\n\nNausea or vomiting\n\nDiarrhea\n\nHeadache\n\nIncreased urination\n\nLow blood sugar (hypoglycemia), especially when meals are skipped\n\nLess Common Side Effects\n\nUrinary tract infections\n\nDizziness or weakness\n\nMild dehydration\n\nRare but Serious Effects\n\nSevere hypoglycemia\n\nLactic acidosis (very rare but serious condition linked with metformin)\n\nAllergic reactions\n\nPatients should immediately consult a healthcare professional if they experience unusual symptoms such as severe weakness, difficulty breathing, or persistent stomach pain.\n\nPrecautions and Safety Advice\n\nBefore starting GLIDAPAFLOZIN TRIO 2, patients should inform their doctor if they have:\n\nKidney disease\n\nLiver problems\n\nHeart conditions\n\nHistory of severe dehydration\n\nAny known drug allergies\n\nPatients should also avoid skipping meals and maintain proper hydration to reduce the risk of low blood sugar.\n\nRegular monitoring of blood glucose levels is important while using this medication.\n\nLifestyle Tips for Better Results\n\nMedication alone cannot control diabetes. Patients should combine treatment with healthy habits.\n\nRecommended lifestyle practices include:\n\nMaintaining a balanced diabetic diet\n\nExercising regularly\n\nMonitoring blood sugar levels\n\nAvoiding excessive sugar and processed foods\n\nManaging stress levels\n\nGetting sufficient sleep\n\nThese lifestyle changes enhance the effectiveness of diabetes medications.\n\nConclusion\nManaging diabetes requires a consistent and comprehensive approach. Combination medicines like GLIDAPAFLOZIN TRIO 2 provide an effective solution for patients who need stronger glucose control than single-drug therapy can offer.", "price": 184.0, "discountamount": 56.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2317, "imageuri": "https://productimages.withfloats.com/actual/69a9837cad119d5b47141190.png", "tileimageuri": "https://productimages.withfloats.com/tile/69a9837cad119d5b47141190.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-03-05T13:22:02.718Z", "updatedon": "2026-03-13T11:05:08.762Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//dapagliflozin-glimepiride-metformin-tablet/2317", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPAFLOZIN TRIO 2", "category": "DIABETIC RANGE", "tags": [ "dapagliflozin glimepiride metformin tablet uses and dosage", "dapagliflozin glimepiride metformin combination tablet benefits", "dapagliflozin glimepiride metformin tablet side effects in adults", "dapagliflozin glimepiride metformin tablet how it works", "dapagliflozin glimepiride metformin tablet benefits for sugar control", "buy dapagliflozin glimepiride metformin tablet online", "dapagliflozin glimepiride metformin tablet price in india", "dapagliflozin glimepiride metformin tablet for uncontrolled diabetes", "dapagliflozin glimepiride metformin tablet triple therapy medicine", "dapagliflozin glimepiride metformin tablet dosage guide for adults" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "696e129c1d5e7fc4677fb603", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "metformin hydrochloride 850 mg and Glimepiride 2 mg", "description": "Diabetes mellitus is one of the most common chronic lifestyle disorders worldwide, affecting millions of people and requiring long-term management. Type 2 diabetes, in particular, occurs when the body either does not produce enough insulin or cannot use insulin effectively. To manage this condition successfully, combination therapy is often recommended when a single medicine is not sufficient to control blood sugar levels.\n\nMetformin Hydrochloride 850 mg and Glimepiride 2 mg Tablets, marketed under the brand name SEIZMET G2 850, is a well-established and effective oral anti-diabetic combination. It is designed to control blood glucose levels through dual action, addressing both insulin resistance and inadequate insulin secretion.\n\nWhat is SEIZMET G2 850?\n\nSEIZMET G2 850 is a combination of two powerful anti-diabetic agents:\n\nMetformin Hydrochloride 850 mg\n\nGlimepiride 2 mg\n\nThis combination is widely prescribed for adults with Type 2 diabetes mellitus when diet, exercise, and monotherapy do not provide adequate glycemic control. By combining two complementary mechanisms, SEIZMET G2 850 helps achieve better and more stable blood sugar management.\n\nUses of Metformin Hydrochloride 850 mg and Glimepiride 2 mg Tablets\n\nThe primary use of SEIZMET G2 850 is the management of Type 2 diabetes mellitus. It is prescribed to:\n\nLower elevated blood glucose levels\n\nImprove insulin sensitivity\n\nEnhance insulin secretion from the pancreas\n\nPrevent diabetes-related complications\n\nThis medicine is especially beneficial for patients who experience persistent high blood sugar despite lifestyle modifications or single-drug therapy.\n\nHow SEIZMET G2 850 Works\n\nSEIZMET G2 850 works through a dual-action mechanism, ensuring effective blood sugar control throughout the day.\n\nRole of Metformin Hydrochloride\n\nMetformin primarily works by:\n\nReducing glucose production in the liver\n\nImproving insulin sensitivity in muscle and fat tissues\n\nDecreasing glucose absorption from the intestine\n\nIt does not cause excessive insulin release, which makes it less likely to cause hypoglycemia when used alone.\n\nRole of Glimepiride\n\nGlimepiride belongs to the sulfonylurea class and works by:\n\nStimulating the pancreas to release insulin\n\nImproving the body’s response to insulin\n\nLowering post-meal blood sugar spikes\n\nTogether, these actions make SEIZMET G2 850 a comprehensive and balanced treatment option for diabetes control.\n\nKey Benefits of SEIZMET G2 850\n\nSEIZMET G2 850 offers several important benefits for patients with Type 2 diabetes:\n\n1. Effective Blood Sugar Control\n\nThe combination ensures both fasting and post-prandial glucose levels remain within the target range.\n\n2. Dual Mechanism for Better Results\n\nBy addressing insulin resistance and insulin deficiency simultaneously, it provides superior glycemic control compared to single-drug therapy.\n\n3. Reduces Risk of Diabetes Complications\n\nProper blood sugar control helps reduce the risk of complications such as nerve damage, kidney disease, eye problems, and cardiovascular disorders.\n\n4. Improves Quality of Life\n\nStable glucose levels lead to better energy levels, improved well-being, and fewer diabetes-related symptoms.\n\n5. Convenient Combination Therapy\n\nCombining two medicines in one tablet improves patient compliance and simplifies daily medication routines.\n\nDosage and Administration\n\nThe dosage of SEIZMET G2 850 should be determined by a healthcare professional based on:\n\nBlood glucose levels\n\nAge and body weight\n\nKidney and liver function\n\nIndividual response to treatment\n\nThe tablet is usually taken once or twice daily with meals to reduce the risk of stomach upset and hypoglycemia. Patients should take the medicine at the same time each day for best results.\n\nIt is important to follow dietary advice, regular exercise, and blood glucose monitoring alongside medication.\n\nPossible Side Effects of SEIZMET G2 850\n\nLike all medicines, Metformin Hydrochloride 850 mg and Glimepiride 2 mg Tablets may cause side effects in some individuals.\n\nCommon Side Effects\n\nNausea\n\nDiarrhea\n\nAbdominal discomfort\n\nHeadache\n\nDizziness\n\nThese side effects are usually mild and temporary and often improve as the body adjusts to the medication.\n\nLess Common but Serious Side Effects\n\nHypoglycemia (low blood sugar), especially if meals are skipped\n\nLactic acidosis (rare but serious, associated with metformin)\n\nAllergic reactions such as skin rash or itching\n\nLiver function abnormalities\n\nPatients should seek medical attention if they experience symptoms such as excessive sweating, confusion, extreme weakness, breathing difficulty, or persistent stomach pain.\n\nPrecautions and Warnings\n\nSEIZMET G2 850 should be used only under medical supervision.\n\nPatients with kidney, liver, or heart disease should inform their doctor before use.\n\nAlcohol consumption should be avoided, as it may increase the risk of side effects.\n\nPregnant and breastfeeding women should consult their doctor before taking this medicine.\n\nRegular monitoring of blood sugar levels is essential to avoid hypoglycemia or uncontrolled diabetes.\n\nWho Should Use SEIZMET G2 850?\n\nSEIZMET G2 850 is suitable for:\n\nAdults diagnosed with Type 2 diabetes\n\nPatients inadequately controlled on metformin or glimepiride alone\n\nIndividuals requiring combination therapy for better glycemic control\n\nIt is not recommended for Type 1 diabetes or diabetic ketoacidosis.\n\nConclusion\n\nMetformin Hydrochloride 850 mg and Glimepiride 2 mg Tablets (SEIZMET G2 850) is a trusted and effective combination therapy for the management of Type 2 diabetes mellitus. By combining the benefits of metformin and glimepiride, it offers comprehensive blood sugar control, reduces the risk of long-term complications, and improves overall quality of life.", "price": 102.0, "discountamount": 30.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2280, "imageuri": "https://productimages.withfloats.com/actual/696e12d9cb45a8390116f1bf.png", "tileimageuri": "https://productimages.withfloats.com/tile/696e12d9cb45a8390116f1bf.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-19T11:16:44.772Z", "updatedon": "2026-03-13T11:01:31.908Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//metformin-hydrochloride-850-mg-and-glimepiride-2-mg/2280", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SEIZMET G2 850", "category": "DIABETIC RANGE", "tags": [ "metformin hydrochloride 850 mg and glimepiride 2 mg tablets", "metformin 850 mg glimepiride 2 mg combination tablet", "glimepiride 2 mg with metformin 850 mg tablets", "metformin glimepiride fixed dose combination tablets", "metformin 850 mg glimepiride 2 mg dosage", "metformin glimepiride tablets for type 2 diabetes", "metformin and glimepiride tablets uses in diabetes", "metformin 850 mg glimepiride 2 mg for blood sugar control", "metformin glimepiride tablets mechanism of action", "metformin glimepiride tablets benefits", "metformin 850 mg glimepiride 2 mg side effects", "metformin glimepiride tablets precautions", "glimepiride metformin tablets safety in diabetes", "metformin glimepiride tablets contraindications", "metformin glimepiride tablets warnings", "metformin glimepiride tablets dosage guidelines", "how to take metformin 850 mg and glimepiride 2 mg tablets", "metformin glimepiride tablets before or after food", "metformin glimepiride tablets daily dose", "metformin glimepiride tablets price in India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694e56c05837f90c86a7eb8c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "empagliflozin linagliptin and metformin", "description": "LINALIGIP EMPAMET (Empagliflozin, Linagliptin, and Metformin Hydrochloride ER Tablets) stands out as a comprehensive triple therapy for adults with type 2 diabetes mellitus, combining three synergistic agents to tackle hyperglycemia from multiple angles. This once-daily extended-release formulation simplifies adherence while delivering robust glycemic control, weight management, and cardiovascular protection. Patients often seek it for its convenience in managing blood sugar levels when diet, exercise, and single agents fall short.\n​\n\nProduct Description and Composition\nLINALIGIP EMPAMET features Empagliflozin (typically 10-25mg), Linagliptin (5 mg), and Metformin Hydrochloride ER (up to 1000mg) in a single tablet, designed for prolonged release to minimize gastrointestinal upset. Empagliflozin, an SGLT2 inhibitor, blocks glucose reabsorption in the kidneys, promoting its excretion via urine. Linagliptin, a DPP-4 inhibitor, enhances incretin hormones like GLP-1 to boost insulin secretion and suppress glucagon. Metformin ER reduces hepatic glucose production and improves insulin sensitivity without hypoglycemia risk.\n​\n\nThis unique blend from Steris Healthcare ensures steady drug delivery over 24 hours, reducing peak-trough fluctuations for stable HbA1c reductions of 1.5-2.0%. The extended-release metformin coats the tablet core, dissolving gradually in the intestines for better tolerability compared to immediate-release forms. Ideal for Indian patients facing rising diabetes prevalence, it addresses insulin resistance, postprandial spikes, and caloric overload holistically.\n​\n\nMechanism of Action\nThe triple mechanism targets key diabetes pathways: Empagliflozin inhibits SGLT2 in proximal renal tubules, lowering blood glucose by 70-90g daily through glycosuria, independent of insulin. Linagliptin selectively binds DPP-4, prolonging GLP-1 and GIP activity to stimulate glucose-dependent insulin release from beta cells and curb glucagon-mediated gluconeogenesis. Metformin activates AMPK in hepatocytes, inhibiting gluconeogenesis while enhancing peripheral glucose uptake.\n​\n\nSynergy amplifies effects—SGLT2 inhibition provides insulin-independent control, DPP-4 boosts prandial responses, and metformin tackles fasting hyperglycemia—resulting in complementary HbA1c drops without overlapping toxicities. Clinical data show this combination yields superior efficacy over dual therapies, with added osmotic diuresis aiding fluid balance.\n​\n\nUses and Indications\nLINALIGIP EMPAMET treats type 2 diabetes in adults, as adjunct to diet and exercise, especially when metformin alone or dual therapy inadequately controls glycemia. Primary uses include newly diagnosed patients needing intensification, those with obesity (due to weight loss from glycosuria), and high-risk cardiovascular profiles benefiting from empagliflozin's heart protection. It excels in managing postprandial hyperglycemia, fasting glucose, and preventing complications like nephropathy.\n​\n\nPrescribed for patients intolerant to other agents or requiring simplified regimens, it suits Indian demographics with high metabolic syndrome rates. Not for type 1 diabetes or ketoacidosis; renal function (eGFR >45 mL/min) guides initiation.\n​\n\nKey Benefits\nLINALIGIP EMPAMET offers multifaceted advantages for long-term diabetes management:\n\nSuperior Glycemic Control: Achieves 1.8% HbA1c reduction in trials, outperforming monotherapies by targeting multiple defects.\n​\n\nWeight Loss: Empagliflozin induces 3-5kg loss via caloric excretion, countering metformin's neutral effect.\n​\n\nCardiovascular and Renal Protection: Reduces major adverse cardiac events (MACE) by 14% and slows CKD progression, per EMPA-REG outcomes.\n​\n\nLow Hypoglycemia Risk: Glucose-dependent actions of linagliptin and empagliflozin minimize lows, unlike sulfonylureas.\n​\n\nConvenience: Single-tablet ER dosing improves compliance, vital for busy lifestyles in Jaipur and beyond.\n​\n\nBlood Pressure Reduction: Mild diuretic effect lowers systolic BP by 3-5 mmHg.\n​\n\nThese benefits enhance quality of life, reducing fatigue, neuropathy risks, and healthcare costs.\n\nSide Effects\nCommon side effects mirror individual components but occur less due to synergy:\n\nGastrointestinal: Metformin ER causes less nausea/diarrhea (10-15%) than IR forms; titrate slowly.\n​\n\nGenitourinary: Empagliflozin raises UTI/genital mycotic infection risk (5-10%), managed with hygiene.\n​\n\nVolume Depletion: Orthostatic hypotension in 2-3%, especially with diuretics.\n​\n\nSerious effects include lactic acidosis (rare, <1/100,000 with metformin in eGFR >30), ketoacidosis (euglycemic, 0.1%), and acute kidney injury. Monitor for dehydration, pancreatitis signs, or bullous pemphigoid with linagliptin. Hypersensitivity rash or bone fractures warrant discontinuation.\n​\n\nSide Effect Category\tFrequency\tManagement\nNausea and Diarrhea\tCommon (10%)\tTake with food, slow titration \n​\nUTI/Mycotic Infections\tCommon (7%)\tHydration, antifungals \n​\nHypoglycemia\tRare (<2%)\tWith insulin, dose adjust \n​\nLactic Acidosis\tVery Rare.\tAvoid in renal/hepatic failure \n​\nKetoacidosis\tRare (0.1%)\tCheck ketones if nausea \n​\nDosage and Administration\nStart with Empagliflozin 10mg/Linagliptin 5mg/Metformin ER 1000mg once daily with morning meal to optimize absorption and reduce GI effects. Titrate metformin to 2000mg max based on tolerance; empagliflozin to 25mg if needed. Swallow whole; no crushing. Adjust for renal impairment (eGFR 30-45: max metformin 1000mg; <30 contraindicated). Elderly start low due to volume sensitivity.\n​\n\nMissed dose: Take soon if less than 12 hours late; skip otherwise. Discontinue pre-surgery or contrast use.\n\nPrecautions and Warnings\nAssess eGFR before and 3-6 months after initiation; hold if <45. Caution in dehydration, heart failure, or liver disease risks lactic acidosis. Educate on ketoacidosis symptoms (nausea, fatigue) despite normal glucose. Avoid excessive alcohol; monitor BP in hypertensives. Pregnancy category D—use insulin instead. Breastfeeding is contraindicated.\n​\n\nDrug interactions: Adding sulfonylureas/insulin heightens hypoglycemia; rifampin reduces linagliptin levels; ritonavir boosts empagliflozin exposure.\n\nFrequently Asked Questions\nWhat is LINALIGIP EMPAMET used for?\nControls type 2 diabetes via triple action on glucose excretion, incretins, and insulin sensitivity.\n​\nDoes it cause weight gain?\nNo—it promotes 2-4 kg loss, unlike some antidiabetics.\n​\n\nSafe for kidneys?\nRenal-protective; monitor eGFR.\n​\n\nHypoglycemia risk?\nMinimal without sulfonylureas.\n\nConclusion\nLINALIGIP EMPAMET revolutionizes type 2 diabetes care with its potent, convenient triple therapy, delivering glycemic mastery, weight benefits, and cardioprotection unmatched by singles or duos. Backed by landmark trials, it empowers patients toward complication-free lives when integrated with lifestyle changes. Consult physicians for personalized dosing to harness its full potential safely.", "price": 220.0, "discountamount": 66.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2257, "imageuri": "https://productimages.withfloats.com/actual/694e60c1db6d50f75e42e875.png", "tileimageuri": "https://productimages.withfloats.com/tile/694e60c1db6d50f75e42e875.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-26T09:34:56.604Z", "updatedon": "2026-03-13T10:59:31Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliflozin-linagliptin-and-metformin/2257", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGIP EMPAMET", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 10 mg", "empagliflozin 25 mg", "empagliflozin 10 mg uses in hindi", "empagliflozin 10 mg tablet.", "type 2 diabetes mellitus.", "linagliptin", "Linagliptin 5 mg", "linagliptin 5 mg uses", "linagliptin tablet uses", "Linagliptin 5 mg price", "Empagliflozin, an SGLT2 inhibitor.", "Metformin ER reduces hepatic glucose production and improves insulin.", "LINALIGIP EMPAMET revolutionizes type 2 diabetes.", "empagliflozin linagliptin and metformin tablets", "empagliflozin linagliptin metformin combination tablet", "empagliflozin linagliptin metformin tablets uses", "empagliflozin linagliptin metformin triple combination", "empagliflozin linagliptin metformin dosage strength", "empagliflozin linagliptin metformin sustained release tablet", "empagliflozin linagliptin metformin medicine for diabetes", "empagliflozin linagliptin metformin tablet uses", "empagliflozin linagliptin metformin benefits", "empagliflozin linagliptin metformin for type 2 diabetes", "empagliflozin linagliptin metformin blood sugar control", "empagliflozin linagliptin metformin weight loss benefit", "what is empagliflozin linagliptin metformin tablet", "how does empagliflozin linagliptin metformin work", "empagliflozin linagliptin metformin tablet price in india", "empagliflozin linagliptin metformin tablet dosage", "empagliflozin linagliptin metformin before or after food" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694cf85408591c1173b54c2f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Pregabalin Epalrestat and Methylcobalamin Tablets", "description": "EPSTATE ED represents an advanced pharmaceutical formulation that combines three powerful therapeutic agents: Pregabalin, Epalrestat, and Methylcobalamin. This innovative triple-combination medication is specifically designed to address the complex pathophysiology of diabetic neuropathy and neuropathic pain conditions. By integrating multiple mechanisms of action, EPSTATE ED offers a comprehensive approach to managing nerve-related complications that significantly impact the quality of life for millions of individuals worldwide.\nThe formulation addresses not only the symptomatic relief of neuropathic pain but also targets the underlying metabolic derangements that contribute to nerve damage progression. This multi-pronged therapeutic strategy makes EPSTATE ED particularly valuable for patients who require more than symptomatic management alone.\nUnderstanding the Active Components\nPregabalin: The Neuropathic Pain Modulator\nPregabalin serves as the cornerstone analgesic component in EPSTATE ED. This anticonvulsant medication works by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system. Through this mechanism, Pregabalin reduces the release of excitatory neurotransmitters including glutamate, norepinephrine, and substance P. This reduction in neurotransmitter release effectively dampens the abnormal neural signaling that characterizes neuropathic pain conditions.\nThe molecule demonstrates excellent bioavailability and rapid absorption, allowing patients to experience relief within a relatively short timeframe. Its efficacy in managing various neuropathic pain syndromes has been extensively documented in clinical trials, establishing it as a first-line agent for diabetic peripheral neuropathy, postherpetic neuralgia, and other chronic neuropathic pain conditions.\nEpalrestat: The Aldose Reductase Inhibitor\nEpalrestat represents a unique addition to the formulation, functioning as a selective aldose reductase inhibitor. In diabetic conditions, excess glucose is converted to sorbitol through the polyol pathway, with aldose reductase serving as the rate-limiting enzyme. The accumulation of sorbitol within nerve cells leads to osmotic stress, depletion of myoinositol, and subsequent nerve dysfunction.\nBy inhibiting aldose reductase, Epalrestat prevents this harmful sorbitol accumulation, thereby addressing one of the fundamental metabolic abnormalities responsible for diabetic neuropathy. This disease-modifying approach distinguishes EPSTATE ED from purely symptomatic treatments. Epalrestat has been particularly well-studied in Asian populations and has demonstrated the ability to improve nerve conduction velocities and reduce subjective neuropathic symptoms over time.\nMethylcobalamin: The Neurotropic Vitamin\nMethylcobalamin, the bioactive form of Vitamin B12, completes the therapeutic triad in EPSTATE ED. Unlike cyanocobalamin, which requires conversion in the body, methylcobalamin is immediately available for utilization in crucial biochemical processes. It plays an indispensable role in myelin synthesis, the protective sheath surrounding nerve fibers that enables proper signal transmission.\nThis coenzyme participates in methionine synthesis and is essential for maintaining the structural and functional integrity of neurons. Methylcobalamin also facilitates nerve regeneration and has demonstrated neuroprotective properties in various experimental models. For patients with diabetic neuropathy, who often exhibit Vitamin B12 deficiency (sometimes exacerbated by metformin therapy), supplementation with methylcobalamin addresses both nutritional deficits and supports nerve health at a fundamental level.\nClinical Applications and Uses\nEPSTATE ED is primarily indicated for the comprehensive management of diabetic peripheral neuropathy, a condition affecting approximately 50% of individuals with long-standing diabetes. The symptoms of this condition range from tingling sensations and burning pain to numbness and loss of protective sensation, which can lead to serious complications including foot ulcers and amputations.\nBeyond diabetic neuropathy, EPSTATE ED may be prescribed for various neuropathic pain syndromes where the combination of pain relief, metabolic correction, and nerve support proves beneficial. Patients experiencing chronic nerve pain resulting from metabolic disturbances, nutritional deficiencies, or structural nerve damage may find this combination particularly effective.\nThe medication is typically recommended for adults who have not achieved adequate symptom control with single-agent therapy or who would benefit from the synergistic effects of the three components. Healthcare providers may prescribe EPSTATE ED when a patient requires both immediate symptom relief and long-term disease modification.\nKey Benefits and Therapeutic Advantages\nComprehensive Multi-Mechanism Action\nThe primary advantage of EPSTATE ED lies in its multi-faceted approach to neuropathic conditions. Rather than addressing only pain symptoms, the formulation simultaneously tackles pain perception, underlying metabolic abnormalities, and nutritional support for nerve health. This comprehensive strategy may lead to superior outcomes compared to monotherapy approaches.\nEnhanced Pain Relief\nClinical evidence supporting Pregabalin's efficacy in neuropathic pain is substantial. Patients often report significant reductions in pain intensity, improved sleep quality due to decreased nocturnal pain, and enhanced ability to perform daily activities. The pain-relieving effects typically manifest within the first week of therapy and continue to improve with ongoing treatment.\nDisease Modification Potential\nUnlike purely symptomatic treatments, the inclusion of Epalrestat provides genuine disease-modifying potential. By targeting the polyol pathway, EPSTATE ED may slow the progression of nerve damage in diabetic patients. Long-term use may preserve nerve function and prevent the worsening of neuropathic symptoms, offering hope beyond mere symptom management.\nImproved Nerve Conduction and Function\nThe combination of metabolic correction through Epalrestat and neurotropic support via Methylcobalamin creates an environment conducive to nerve regeneration and functional improvement. Studies have demonstrated improvements in nerve conduction velocity parameters with similar combination therapies, suggesting potential restoration of nerve function rather than simple symptom masking.\nConvenience of Combination Therapy\nFor patients who would otherwise require multiple separate medications, EPSTATE ED offers the convenience of a single tablet containing all three therapeutic agents. This simplification of medication regimens improves compliance, reduces pill burden, and may enhance overall treatment outcomes.\nQuality of Life Enhancement\nThe cumulative effect of pain reduction, improved nerve function, and better metabolic control translates into meaningful quality of life improvements. Patients report better mobility, reduced interference of pain with daily activities, improved mood, and enhanced social functioning.\nPotential Side Effects and Safety Considerations\nCommon Side Effects\nAs with any pharmaceutical agent, EPSTATE ED may produce certain adverse effects. The most commonly reported side effects are primarily attributable to the Pregabalin component and include dizziness, somnolence, peripheral edema, dry mouth, blurred vision, weight gain, and difficulty with concentration or attention. These effects are generally mild to moderate and often diminish with continued therapy as the body adapts to the medication.\nGastrointestinal symptoms such as constipation or nausea may occur, though they are typically manageable with dietary modifications or symptomatic treatment. Some patients experience increased appetite leading to weight gain, which requires monitoring, particularly in diabetic individuals where weight management is crucial.\nSerious but Rare Adverse Events\nThough uncommon, certain serious adverse effects warrant immediate medical attention. These include allergic reactions manifesting as rash, itching, swelling, severe dizziness, or breathing difficulties. Pregabalin has been associated with rare cases of angioedema, which requires prompt discontinuation and medical intervention.\nMental health changes, including mood alterations, anxiety, depression, agitation, or suicidal thoughts, have been reported with Pregabalin use, particularly in individuals with pre-existing psychiatric conditions. Patients and caregivers should remain vigilant for behavioral changes and report them immediately to healthcare providers.\nDrug Interactions and Precautions\nEPSTATE ED may interact with other central nervous system depressants, including alcohol, opioids, benzodiazepines, and antihistamines, potentially intensifying sedation and cognitive impairment. Patients should inform their healthcare provider of all medications, supplements, and substances they consume.\nIndividuals with kidney impairment require dose adjustments since Pregabalin is primarily eliminated through renal excretion. Regular monitoring of renal function may be necessary during long-term therapy.\nSpecial Population Considerations\nPregnant or breastfeeding women should use EPSTATE ED only when clearly necessary and under strict medical supervision, as the safety profile in these populations has not been fully established. Elderly patients may be more susceptible to side effects, particularly dizziness and confusion, necessitating careful dose titration and monitoring.\nPatients should be advised against abrupt discontinuation of EPSTATE ED, as sudden cessation of Pregabalin may precipitate withdrawal symptoms including insomnia, nausea, headache, anxiety, and sweating. Gradual dose reduction under medical supervision is recommended when discontinuing therapy.\nDosage and Administration Guidelines\nThe appropriate dosage of EPSTATE ED is highly individualized and should be determined by a qualified healthcare professional based on the patient's specific condition, response to therapy, and tolerance. Typically, treatment begins with a lower dose that is gradually increased to achieve optimal therapeutic benefit while minimizing adverse effects.\nPatients should take EPSTATE ED exactly as prescribed, with or without food, at consistent times each day to maintain stable blood levels. Missing doses should be addressed by taking the forgotten dose as soon as remembered, unless it's nearly time for the next scheduled dose. Double dosing to compensate for missed doses is not recommended.\nRegular follow-up appointments allow healthcare providers to assess treatment efficacy, monitor for adverse effects, and make necessary dose adjustments. Patients should maintain open communication with their medical team regarding symptom improvement, side effects, and any concerns that arise during therapy.\nPatient Counseling and Lifestyle Recommendations\nMaximizing the benefits of EPSTATE ED extends beyond simply taking the medication. Patients should be counseled on complementary lifestyle measures that support neuropathy management. Maintaining optimal glycemic control remains paramount for diabetic patients, as blood sugar management directly impacts neuropathy progression regardless of medication.\nRegular physical activity, within individual capabilities, promotes circulation, supports nerve health, and may enhance the therapeutic effects of EPSTATE ED. Daily foot examinations become critical for diabetic patients to identify potential injuries early, preventing serious complications.\nNutritional optimization, including adequate intake of B vitamins, antioxidants, and essential nutrients, supports the neurotropic effects of Methylcobalamin. Avoiding alcohol and tobacco, both of which can exacerbate neuropathy, is strongly recommended.\nPatients should be cautioned about activities requiring alertness, such as driving or operating machinery, especially during the initial treatment phase when dizziness and somnolence may be more pronounced. These effects typically improve with continued therapy, but individual responses vary.\nConclusion\nEPSTATE ED represents a thoughtfully designed pharmaceutical formulation that addresses the multifaceted nature of diabetic neuropathy and neuropathic pain through its unique combination of Pregabalin, Epalrestat, and Methylcobalamin. This triple-action approach offers patients more than symptomatic relief—it provides genuine disease modification potential, nutritional support, and comprehensive nerve health optimization.\nThe synergistic effects of these three components create a therapeutic profile that is greater than the sum of its parts. While Pregabalin efficiently manages pain symptoms and improves quality of life in the short term, Epalrestat works to address underlying metabolic derangements that drive disease progression, and Methylcobalamin provides essential neurotropic support for nerve regeneration and function.\nFor patients struggling with the debilitating effects of neuropathic pain and diabetic neuropathy, EPSTATE ED offers renewed hope for better symptom control and potentially slowed disease progression. The convenience of combination therapy in a single tablet improves adherence and simplifies complex treatment regimens.\nHowever, EPSTATE ED is not without considerations. Potential side effects, though generally manageable, require awareness and monitoring. The medication is most effective when integrated into a comprehensive management plan that includes optimal glycemic control, lifestyle modifications, and regular medical supervision.\nUltimately, EPSTATE ED should be viewed as a valuable tool in the therapeutic arsenal against neuropathic conditions, best utilized under the guidance of knowledgeable healthcare professionals who can individualize treatment to each patient's unique needs and circumstances. With proper use, monitoring, and patient education, EPSTATE ED can significantly improve outcomes and quality of life for those affected by these challenging neurological conditions.", "price": 275.0, "discountamount": 82.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2253, "imageuri": "https://productimages.withfloats.com/actual/694cf859d25fa0b0657b1ac8.png", "tileimageuri": "https://productimages.withfloats.com/tile/694cf859d25fa0b0657b1ac8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-25T08:39:48.947Z", "updatedon": "2026-04-18T09:21:49.885Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//pregabalin-epalrestat-and-methylcobalamin-tablets/2253", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "EPSTATE ED", "category": "NEUROLOGYRANGE", "tags": [ "regabalin, Epalrestat, and Methylcobalamin.neuropathic pain conditions.", "Pregabalin, Epalrestat, and Methylcobalamin.", "neuropathic pain.", "diabetic neuropathy.", "sorbitol within nerve cells leads to osmotic stress.", "Epalrestat and neurotropic support via Methylcobalamin creates an environment .", "mood alterations, anxiety, depression, agitation.", "supports the neurotropic effects of Methylcobalamin.", "Pregabalin Epalrestat and Methylcobalamin Tablets", "epalrestat and methylcobalamin tablets uses", "epalrestat and methylcobalamin tablets in hindi", "pregabalin epalrestat and methylcobalamin tablets price jaipur", "pregabalin epalrestat and methylcobalamin tablets price india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "glimepiride voglibose metformin", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/69abe998ad5b8f3f9ba863c2.png", "tileimageuri": "https://productimages.withfloats.com/tile/69abe998ad5b8f3f9ba863c2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2026-03-13T10:35:41.824Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//glimepiride-voglibose-metformin/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "DIABETIC RANGE", "tags": [ "glimepiride voglibose metformin tablets", "glimepiride voglibose metformin combination", "glimepiride voglibose metformin dosage", "glimepiride voglibose metformin uses", "glimepiride voglibose metformin composition", "glimepiride voglibose metformin tablets ip", "glimepiride voglibose metformin triple combination", "glimepiride voglibose metformin for type 2 diabetes", "triple drug combination for type 2 diabetes", "diabetes medicine for high fasting and pp sugar", "medicine for uncontrolled diabetes type 2", "combination tablets for diabetes management", "combination tablets for diabetes management", "when to take glimepiride voglibose metformin tablets", "who should take glimepiride voglibose metformin", "benefits of glimepiride voglibose metformin tablets", "side effects of glimepiride voglibose metformin" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }